uz
Feedback
Neurology Updates

Neurology Updates

Kanalga Telegram’da o‘tish

All the atest articles, research and news from worlds leading Neurology Journals. Discussion group https://t.me/Professional_Medical_Discussion

Ko'proq ko'rsatish

📈 Telegram kanali Neurology Updates analitikasi

Neurology Updates (@neurology_updates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 16 175 obunachidan iborat bo'lib, Tibbiyot toifasida 1 504-o'rinni va AQSH mintaqasida 2 332-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 16 175 obunachiga ega bo‘ldi.

05 Sentabr, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 311 ga, so‘nggi 24 soatda esa 5 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 6.93% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.64% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 1 121 marta ko‘riladi; birinchi sutkada odatda 427 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 1 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent disease, stroke, alzheimer, cell, dementia kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
All the atest articles, research and news from worlds leading Neurology Journals. Discussion group https://t.me/Professional_Medical_Discussion

Yuqori yangilanish chastotasi (oxirgi ma’lumot 06 Sentabr, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

16 175
Obunachilar
+524 soatlar
+467 kun
+31130 kun
Obunachilarni jalb qilish
Sentabr '26
Sentabr '26
+34
0 kanalda
Avgust '26
+363
0 kanalda
Get PRO
Iyul '26
+419
0 kanalda
Get PRO
Iyun '26
+379
0 kanalda
Get PRO
May '26
+451
0 kanalda
Get PRO
Aprel '26
+353
0 kanalda
Get PRO
Mart '26
+133
0 kanalda
Get PRO
Fevral '26
+165
0 kanalda
Get PRO
Yanvar '26
+212
0 kanalda
Get PRO
Dekabr '25
+188
0 kanalda
Get PRO
Noyabr '25
+233
2 kanalda
Get PRO
Oktabr '25
+263
0 kanalda
Get PRO
Sentabr '25
+270
0 kanalda
Get PRO
Avgust '25
+434
0 kanalda
Get PRO
Iyul '25
+435
0 kanalda
Get PRO
Iyun '25
+288
0 kanalda
Get PRO
May '25
+295
0 kanalda
Get PRO
Aprel '25
+351
0 kanalda
Get PRO
Mart '25
+358
0 kanalda
Get PRO
Fevral '25
+368
0 kanalda
Get PRO
Yanvar '25
+629
2 kanalda
Get PRO
Dekabr '24
+636
0 kanalda
Get PRO
Noyabr '24
+857
0 kanalda
Get PRO
Oktabr '24
+902
0 kanalda
Get PRO
Sentabr '24
+922
0 kanalda
Get PRO
Avgust '24
+696
0 kanalda
Get PRO
Iyul '24
+506
2 kanalda
Get PRO
Iyun '24
+500
0 kanalda
Get PRO
May '24
+552
1 kanalda
Get PRO
Aprel '24
+485
0 kanalda
Get PRO
Mart '24
+495
0 kanalda
Get PRO
Fevral '24
+649
0 kanalda
Get PRO
Yanvar '24
+889
0 kanalda
Get PRO
Dekabr '23
+816
1 kanalda
Get PRO
Noyabr '23
+33
0 kanalda
Get PRO
Oktabr '23
+51
0 kanalda
Get PRO
Sentabr '23
+28
0 kanalda
Get PRO
Avgust '23
+43
0 kanalda
Get PRO
Iyul '23
+58
0 kanalda
Get PRO
Iyun '23
+40
0 kanalda
Get PRO
May '23
+32
0 kanalda
Get PRO
Aprel '23
+39
0 kanalda
Get PRO
Mart '23
+52
0 kanalda
Get PRO
Fevral '23
+29
0 kanalda
Get PRO
Yanvar '23
+28
0 kanalda
Get PRO
Dekabr '22
+28
0 kanalda
Get PRO
Noyabr '22
+64
0 kanalda
Get PRO
Oktabr '22
+25
0 kanalda
Get PRO
Sentabr '22
+65
0 kanalda
Get PRO
Avgust '22
+31
0 kanalda
Get PRO
Iyul '22
+22
0 kanalda
Get PRO
Iyun '22
+42
0 kanalda
Get PRO
May '22
+40
0 kanalda
Get PRO
Aprel '22
+23
0 kanalda
Get PRO
Mart '22
+21
0 kanalda
Get PRO
Fevral '22
+11
0 kanalda
Get PRO
Yanvar '22
+22
0 kanalda
Get PRO
Dekabr '21
+23
0 kanalda
Get PRO
Noyabr '21
+15
0 kanalda
Get PRO
Oktabr '21
+28
0 kanalda
Get PRO
Sentabr '21
+21
0 kanalda
Get PRO
Avgust '21
+26
0 kanalda
Get PRO
Iyul '21
+30
0 kanalda
Get PRO
Iyun '21
+65
0 kanalda
Get PRO
May '21
+34
0 kanalda
Get PRO
Aprel '21
+144
0 kanalda
Get PRO
Mart '21
+109
0 kanalda
Get PRO
Fevral '21
+27
0 kanalda
Get PRO
Yanvar '21
+26
0 kanalda
Get PRO
Dekabr '20
+428
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
05 Sentabr+9
04 Sentabr+13
03 Sentabr+7
02 Sentabr+5
01 Sentabr0
Kanal postlari
Neuromodulation for restoring and amplifying brain function https://www.nature.com/articles/s41593-026-02434-6

2
Neural geometry guides learning https://www.nature.com/articles/s41593-026-02442-6
440
3
Structured experience shapes strategy learning and neural dynamics in the medial entorhinal cortex https://www.nature.com/articles/s41593-026-02409-7
598
4
Priming of CD8<sup>+</sup> T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration https://www.nature.com/articles/s41593-026-02427-5
552
5
Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction https://www.nature.com/articles/s41593-026-02421-x
631
6
Glutamate concentration tunes AMPA receptor function through conductance-state occupancy https://www.nature.com/articles/s41593-026-02414-w
584
7
[Articles] Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00276-0/fulltext?rss=yes
703
8
[Comment] Finding more intracranial aneurysms that will never rupture https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00315-7/fulltext?rss=yes
666
9
Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes https://www.nature.com/articles/s41593-026-02419-5
724
10
State-dependent signal flow hierarchy in the human cerebral cortex https://www.nature.com/articles/s41593-026-02389-8
674
11
ATTs in Patients With Non-AD Copathologies https://jamanetwork.com/journals/jamaneurology/fullarticle/2853597
739
12
Tirofiban for Branch Atheromatous Disease–Related Stroke https://jamanetwork.com/journals/jamaneurology/fullarticle/2853598
681
13
Treatment Discontinuation in MOGAD—One Size Does Not Fit All—Reply https://jamanetwork.com/journals/jamaneurology/fullarticle/2853599
610
14
Treatment Discontinuation in MOGAD—One Size Does Not Fit All https://jamanetwork.com/journals/jamaneurology/fullarticle/2853600
693
15
Tirofiban for Branch Atheromatous Disease https://jamanetwork.com/journals/jamaneurology/fullarticle/2853601
730
16
Spatial mapping of RNA turnover kinetics in the mouse brain https://www.nature.com/articles/s41593-026-02420-y
845
17
https://www.instagram.com/updates_in_medicine?igsi=eWJ2N3p2MmxvNXJ0&utm_source=qr
https://www.instagram.com/updates_in_medicine?igsi=eWJ2N3p2MmxvNXJ0&utm_source=qr
587
18
Social isolation recruits amygdala–medial prefrontal cortex projections to escalate alcohol drinking in male mice https://www.nature.com/articles/s41593-026-02413-x
1 524
19
[Articles] Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00278-4/fulltext?rss=yes
1 370
20
[Comment] Targeting orexin signalling in narcolepsy https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00316-9/fulltext?rss=yes
1 127